Sarcoidosis and the heart

被引:12
作者
Ralph Shabetai
机构
[1] Veterans Affairs Health Care System,Cardiology 111A
关键词
Cardiomyopathy; Digoxin; Sarcoidosis; International Normalize Ratio; Dilate Cardiomyopathy;
D O I
10.1007/s11936-000-0034-x
中图分类号
学科分类号
摘要
The treatment of sarcoid cardiomyopathy can be considered in part the treatment of the systemic disorder, and in part cardiac involvement, the manifestations of which may differ greatly. Therapy for the systemic disease is corticosteroid. Therapy for cardiac involvement includes prednisone, but because treatment must ameliorate or abolish many differing manifestations, therapy differs among patients.Asymptomatic patients (the majority) who are free from serious manifestations of the disease do not require pharmacologic or interventional treatment.Patients with dilated cardiomyopathy require treatment for congestive heart failure.High-grade atrioventricular conduction delay usually necessitates a permanent electronic pacemaker.Life-threatening arrhythmia usually requires implantation of an automatic implantable cardiac defibrillator (AICD). Antiarrhythmic drugs may also be needed.Cardiac tamponade should be treated by drainage of pericardial fluid.Pericardiectomy is usually the appropriate treatment for patients who develop significant constrictive pericarditis.Calcium channel blockers may be helpful for severe diastolic dysfunction that occurs in those with restrictive cardiomyopathy.Therapy should be given to those few patients who manifest hypertrophic cardiomyopathy to relieve left ventricular outflow obstruction.Cardiac transplantation for intractable heart failure or arrhythmia may be needed.
引用
收藏
页码:385 / 397
页数:12
相关论文
共 50 条
[1]  
Crystal RG(1981)Pulmonary sarcoidosis, a disease characterized by and activated by lung T lymphocytes Ann Int Med 94 73-94
[2]  
Yasaki Y(1998)Comparison of clinical features and prognosis of cardiac sarcoidosis Am J Cardiol 82 537-540
[3]  
Isobar M(1994)Successful treatment of myocardial sarcoidosis with steroids Sarcoidosis 11 37-39
[4]  
Hermits S(1990)Steroid responsive cardiomyopathy Int J Cardiol 28 257-258
[5]  
Shamas RL(1997)Idiopathic giant-cell myocarditis—natural history and treatment N Engl J Med 336 1860-1866
[6]  
Movahed A(1996)Giant cell myocarditis: an entity distinct from sarcoidosis characterized by multiphasic myocyte destruction by cytotoxic T cells and histiocytic giant cells Mod Pathol 9 1126-1134
[7]  
Probert CS(1991)Giant cell versus lymphocytic myocarditis. A comparison of their clinical features and long term outlook Circulation 83 953-961
[8]  
Pavord I(2000)Idiopathic dilated cardiomyopathy Curr Treat Option Cardiovasc Med 2 421-430
[9]  
Roland J(1996)Effectiveness of spironolactone added to an angiotensin converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure Am J Cardiol 78 902-907
[10]  
Cooper LT(1997)The effects of digoxin on mortality and morbidity in patients with heart failure N Eng J Med 336 524-533